Editorial
Copyright ©The Author(s) 2015.
World J Gastrointest Pathophysiol. Nov 15, 2015; 6(4): 90-98
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.90
Table 1 Randomized controlled trials evaluating the treatment of alcoholic hepatitis
StudyTopicMethodsFindings
Prednisolone or pentoxifylline
Theodossi et al[99]PRED vs placeboRandomized controlNo difference in mortality
Ramond et al[100]PRED vs placeboDouble-blinded, randomized controlImproved mortality with PRED
Akriviadis et al[69]PTX vs placeboDouble-blinded, randomized controlImproved mortality with PTX
Sidhu et al[101]PTX vs placeboRandomized controlImproved mortality with PTX
De et al[102]PTX vs PREDDouble-blinded, randomized controlReduced mortality with PTX
Park et al[103]PTX vs PREDRandomized controlReduced mortality with PRED
Mathurin et al[104]PRED vs PRED + PTXMulticenter, double-blinded, randomized controlNo difference in mortality
De et al[105]PTX vs PTX + PREDDouble-blinded, randomized controlNo difference in mortality
Thursz et al[70]PTX vs PRED vs placeboMulticenter, double-blinded, randomized controlNo difference in mortality
N-acetylcysteine
Moreno et al[106]NAC vs placeboMulticenter, single-blinded, randomized controlNo difference in mortality
Cytokine inhibitors
Naveau et al[72]Infliximab vs placeboDouble-blinded, randomized controlIncreased mortality with infliximab
Boetticher et al[71]Etancercept vs placeboMulticenter, single-blinded, randomized controlIncreased mortality with etancercept